PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

15 registration certificates of medicines have been withdrawn from the State Register

The Ministry of Health of the Russian Federation has revoked registration certificates for 15 drugs based on applications from their owners. Of these, 13 belonged to JSC Pharmstandard-Tomskkhimpharm, the rest belonged to JSC Sanofi Russia. Information about this appeared on the GRLS website.

Recalled drugs of JSC Pharmstandard-Tomskkhimpharm: 

“Ethyl alcohol” ((ethanol), LSR-008197/08 dated 10/16/2008);

“Citramon P” (LSR-000021 dated 03/28/2007);

“Furosemide” ((furosemide) LS-000488 dated 11/18/2009);

Prednisone (prednisone) LSR-003276/07 dated 10/17/2007);

“Paracetamol” ((paracetamol) LSR-000062 dated 05/10/2007);

Pantocrine (LSR-003253/07 dated 17.10.2007);

“Nitrosorbide” ((isosorbide dinitrate) LSR-003429/07 dated 10/26/2007);

Peppermint tincture (LSR-003434/07 dated 10/26/2007);

“Levomycetin” ((chloramphenicol) LS-001979 dated 07/9/2010);

“Potassium orotate” ((orotic acid) LSR-003254/07 dated 17.10.2007);

Hawthorn tincture (LS-002044 from 08/25/2009);

“Acetylsalicylic acid” ((acetylsalicylic acid) R N003094/01 dated 12/15/2008);

“Analgin” ((sodium metamizole), P N001244/01 dated 01/23/2008).

Recalled drugs of Sanofi Russia JSC:

“Troxerutin Sanofi” ((troxerutin) N N015161/01 dated 08/13/2008);

“Tritatse” ((ramipril) LSR-008998/09 dated 09.11.2009).

All drugs excluded from the GRLS have registered analogues on the Russian market.

Current news

  • January 13, 2026

    The average cost of bringing a medicinal product to market has tripled over 20 years

    Over the past 20 years, the average cost of bringing a medicinal product to market…

  • January 13, 2026

    More than 60% of the Russian pharmaceutical market is occupied by foreign drugmakers

    Despite sanctions and expectations of a complete withdrawal of foreign businesses, international pharmaceutical companies continue…

  • January 13, 2026

    The Ministry of Industry and Trade will align the regulatory framework with the transition to EAEU GMP

    The Ministry of Industry and Trade of Russia has prepared a draft government resolution proposing…

  • January 13, 2026

    WHO Director-General: Pandemic agreement to be opened for signature after May

    WHO member states are negotiating an important annex to the agreement — a pathogen access…

  • January 13, 2026

    The Ministry of Industry and Trade proposes extending transition periods related to confirmation of the country of origin of medicines and a number of medical devices

    Relevant draft amendments to resolutions of the Government of the Russian Federation*, prepared by the…

LLC “BioJet”. all rights reserved

  • Legal information